Among carcinoma, SOX10 expression has been most frequently observed in salivary gland carcinoma and breast carcinoma, along with rare expression in head and neck squamous cell carcinoma, clear cell carcinoma, lung adenocarcinoma (LA), urothelial carcinoma, and colorectal carcinoma [14,25]. Here, SOX10 is linked to lung adenocarcinoma.